Oneview Healthcare ("Oneview"), a global leader in digital patient engagement solutions, is excited to announce the launch of its new brand identity, reflecting the company's evolution and reaffirming ...

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Oneview Healthcare Chess Depository Interests repr 1 (ONVVF – Research Report) today and set a price target of A$0.40. The company ...

"OneView, combined with our patient recruitment solutions and services, drives meaningful innovation for sponsors, sites, and most importantly, for patients." OneView simplifies interoperability ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

The OneView patient recruitment portal drives efficiency across all patient referral sources, studies, and sites. Company rebrand underscores innovative change that will disrupt traditional ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...

Jan 30 (Reuters) - Merck (MRK.N), opens new tab plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in ...

Jan 24 (Reuters) - Merck (MRK.N), opens new tab and Japan-based Eisai (4523.T), opens new tab said on Friday a combination of their therapies failed to extend the lives of patients with a type of ...

RAHWAY, N.J., January 28, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly ...

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

Now there’s a new one for the list: cancer prevention vaccines. Merck, which makes the commonly used Gardasil shot, has shed 14 per cent of its market value since announcing last week that it ...